Search
forCommunity 3
Research 10 of 343
- Blockbuster Weight-Loss Drugs Not Tied to Suicidality, Studies Show
- Risk of Suicide, Hair Loss, and Aspiration with GLP1-Receptor Agonists and Other Diabetic Agents: A Real-World Pharmacovigilance Study
- Semaglutide-Induced Atypical Pustular Drug Eruption: A Case Report
- 0439 Temporal–phenotype signatures of alopecia associated with GLP-1–based therapies: A PRISMA-ScR scoping review
- Women with PCOS have a heightened risk of cardiometabolic and cardiovascular diseases: statement from the Experts Group on Inositol in Basic and Clinical Research and PCOS (EGOI-PCOS) and Italian Association of Hospital Cardiologists (ANMCO)
- Impact of Reducing Obesity in PCOS: Methods and Treatment Outcomes
- EFLÚVIO TELÓGENO ASSOCIADO AO USO DE MEDICAMENTOS EMAGRECEDORES: MECANISMOS FISIOPATOLÓGICOS E EVIDÊNCIAS CLÍNICAS
- CURRENT THERAPEUTIC APPROACHES IN THE MANAGEMENT OF POLYCYSTIC OVARY SYNDROME
- current possible treatment approaches of Polycystic Ovary Syndrome (PCOS)
- Editorial: Exploring innovative therapies for rare inflammatory skin diseases
Learn
— no results
Try a deeper search in learn →